 SALT LAKE CITY , June 28, 2022 PRNewswire -- Co-Diagnostics, Inc. Nasdaq: CODX the Company or Co-Dx,, a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be presenting this week at the 29th International Biodetection Technologies Conference, held virtually June 28-29, 2022. The Biodetection Technologies Conference is an internationally recognized meeting for experts in detection identification of biological threats, which this year plans to address the key topics in detection and present the latest RD and technological innovation in ready-to-market systems. 